Homepage | CIDRAP
WebUS respiratory virus activity continues to tail off. Report: Less than half of nursing home residents up to date on COVID vaccines. Tazewell County, Virginia reports first CWD case. Data: Mpox rates steady year-round in Africa, vary by season in Northern Hemisphere tropics. Quick takes: Avian flu in 1 more dairy herd, more US mpox cases, polio ...
COVID-19 | CIDRAP
WebSevere COVID in older adults may be due to greater viral load, weaker immune response. The findings suggest that older patients with severe COVID-19 may respond more favorably to immunomodulatory therapies aimed at certain inflammatory cytokines, the authors say. Mary Van Beusekom.
About CIDRAP | CIDRAP
WebThe Center for Infectious Disease Research and Policy (CIDRAP; "SID-wrap") is a global leader in addressing public health preparedness and emerging infectious disease response. Founded in 2001, CIDRAP is part of the Research and Innovation Office at the University of Minnesota. CIDRAP works to prevent illness and death from targeted infectious ...
Diagnostics | CIDRAP
WebAvails receives additional CARB-X funding for rapid susceptibility test. Diagnostics company Avails Medical announced today that it has received an additional $1.7 million in funding from CARB-X (the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) to continue developing a rapid electronic antibiotic susceptibility test (AST).
All News | CIDRAP
WebThe group steered away from defined cutoff points such as "droplets" and "aerosols" that scientists have used to distinguish larger particles from smaller particles. Nearly half of all physically able vaccine seekers (47%) could walk to COVID-19 vaccination sites within 15 minutes, and 87% could do ...
COVID vaccination in kids protects against serious outcomes, but …
Web5 days ago · Today in Morbidity and Mortality Weekly Report, researchers examine the durability of COVID-19 vaccination during Omicron circulation among kids 5 to 18 years and find that two doses of the original monovalent (single-strain) mRNA COVID-19 vaccine was 52% effective against pediatric COVID-19 hospitalization and 57% effective against critical illness, if the vaccine was administered no longer ...
COVID-19: CIDRAP Commentaries | CIDRAP
WebCOVID-19: The CIDRAP Viewpoint. Starting at the beginning of the pandemic, CIDRAP compiled a groundbreaking of series of reports on key aspects of COVID-19, such as what direction the pandemic might take, how to communicate risks effectively, smart testing for the virus and for antibodies to it, contact tracing, surveillance, ensuring a ...
Our Projects | CIDRAP
WebCIDRAP operates many projects intended to improve knowledge in infectious disease preparedness and response, share expertise with decision makers locally and worldwide, and serve as a resource to assist communities in our region and around the world. We are constantly assessing and adjusting these programs to align with the ever-changing world ...
A New Phase | CIDRAP
WebOct 13, 2022 · Chris Dall: [00:00:06] Hello and welcome to the Osterholm Update COVID-19, a podcast on the COVID-19 pandemic with Dr. Michael Osterholm.Dr. Osterholm is an internationally recognized medical detective and director of the Center for Infectious Disease Research and Policy, or CIDRAP at the University of Minnesota.
SARS | CIDRAP
WebNov 10, 2021 · In the first known estimate of the SARS-CoV spillover risk from bats to people, researchers who studied bat populations in South East Asia and interactions with humans estimate that about 66,280 people a year are infected each year. The team, based at EcoHealth Alliance, published their findings today in Nature Communications.
Skip to content